Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 27 May 21 424B4 Prospectus supplement with pricing info
- 27 May 21 EFFECT Notice of effectiveness
- 26 May 21 S-1/A IPO registration (amended)
-
24 May 21 S-1/A IPO registration (amended)
- 4 May 21 S-1 IPO registration
DAWN similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated March 19, 2021 (except for the third paragraph in Note 1, and Note 17, as to which the date is May 24, 2021), in Amendment No. 1 to the Registration Statement (Form S-1 No. 333-255754) and related Prospectus of Day One Biopharmaceuticals Holding Company, LLC, for the registration of shares of its common stock.
/s/ Ernst & Young LLP
Redwood City, California
May 24, 2021